Skip to main content

Cramer's lightning round: Take a pass on Bristol-Myers Squibb shares for now

Jim Cramer fires off his take on callers' favorite stocks, including a biopharmaceutical play facing a rival.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.